Condition: Corneal Edema · Corneal Endothelial Dysfunction · Fuchs Endothelial Corneal Dysfunction · Sponsor: Aurion Biotech
The purpose of this study is to assess the efficacy and safety of single injection dose of AURN001 compared with placebo in adult participants with corneal edema secondary to corneal endothelial dysfunction.
This description comes directly from the study's public registry record.
Aurion Study Team · 1-857-639-4163 · ASTRA@aurionbiotech.com
Always discuss trial participation with your own doctor first.
| Investigational Site 2 | Mesa, Arizona, United States | Recruiting |
| Investigational Site 6 | Little Rock, Arkansas, United States | Recruiting |
| Investigational Site 9 | Fort Collins, Colorado, United States | Recruiting |
| Investigational Site 7 | Atlanta, Georgia, United States | Recruiting |
| Investigational Site 4 | Kansas City, Missouri, United States | Recruiting |
| Investigational Site 11 | Leland, North Carolina, United States | Recruiting |
| Investigational Site 5 | Winston-Salem, North Carolina, United States | Recruiting |
| Investigational Site 3 | Cynwyd, Pennsylvania, United States | Recruiting |
| Investigational Site 10 | Plymouth Meeting, Pennsylvania, United States | Recruiting |
| Investigational Site 12 | Ladson, South Carolina, United States | Recruiting |
| Investigational Site 8 | San Antonio, Texas, United States | Recruiting |
| Investigational Site 1 | Spring, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07368959